Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Novo Nordisk, Lilly, Novartis Said to Bid for Ascendis Pharma
Bloomberg Businessweek
Friday, July 30, 2010 - 10:55am
tags:
Novo Nordisk, Eli Lilly, Novartis, Ascendis, M&A
Geron rallies as FDA green lights stem cell study
Marketwatch
Friday, July 30, 2010 - 10:52am
tags:
Geron, stem cells, FDA
FDA warning linked to Cubist drug
Bizjournals.com
Friday, July 30, 2010 - 10:47am
tags:
FDA, Cubist Pharmaceuticals, antibiotics, Cubicin
Merck profit drops 51%, adjusted net income rises
Marketwatch
Friday, July 30, 2010 - 10:45am
tags:
Merck, earnings
Sanofi-Aventis to Genzyme: Game On
Seeking Alpha
Friday, July 30, 2010 - 10:43am
tags:
Sanofi, Genzyme, M&A, AstraZeneca
Charles River, WuXi Make Mutual Decision To End Deal
WSJ Online
Friday, July 30, 2010 - 12:29am
tags:
Charles River Laboratories, WuXi PharmaTech, M&A
Amgen Q2 Beats, Driven by International Sales
Barron's
Friday, July 30, 2010 - 12:25am
tags:
Amgen, earnings
Is Abbott a Buy?
Motley Fool
Friday, July 30, 2010 - 12:23am
tags:
Abbott Laboratories, Humira, Solvay
Neurocrine Looks Well Positioned
Yahoo/AP
Friday, July 30, 2010 - 12:22am
tags:
Neurocrine, Abbott Laboratories, GSK, GnRH antagonists
Hospira plans big study for new Epogen biosimilar
Fierce Biotech
Thursday, July 29, 2010 - 3:24pm
tags:
Hospira, Epogen, biosimilars, generics, anemia
Forget Respect -- Dendreon Needs Sales!
Motley Fool
Thursday, July 29, 2010 - 3:21pm
tags:
Dendreon, Provenge, prostate cancer
Sanofi To Send 'Bear Hug' Letter Within 72 Hours
CNBC
Thursday, July 29, 2010 - 3:20pm
tags:
M&A, Sanofi, Genzyme
4-Star Stocks Poised to Pop: Eli Lilly
Motley Fool
Thursday, July 29, 2010 - 3:17pm
tags:
Eli Lilly
Who is Killing the Pharmaceutical Sales Position?
Pharmareform
Thursday, July 29, 2010 - 11:01am
tags:
drug reps
Celgene Beats and Raises Guidance
TheStreet.com
Thursday, July 29, 2010 - 10:59am
tags:
Celgene, earnings
FTC: ‘Tide May Be Turning’ On Pay-To-Delay Deals
Pharmalot
Thursday, July 29, 2010 - 10:55am
tags:
FTC, pay-for-delay, Apotex, Watson Pharmaceuticals, Solvay, Abbott Laboratories, generics
Sanofi Board Said to Support Genzyme Bid of Up to $18.7 Billion
Bloomberg
Thursday, July 29, 2010 - 10:50am
tags:
Genzyme, M&A, Sanofi
Even After Patent Cliff, Pfizer Is Undervalued
Yahoo/Morningstar
Thursday, July 29, 2010 - 10:48am
tags:
Pfizer, patents
Bayer Cuts Full-Year Forecasts at Two of Three Units as Profit Declines
Bloomberg
Thursday, July 29, 2010 - 10:40am
tags:
Bayer, earnings
Sanofi Second-Quarter Profit Climbs 7.6% on Demand for Diabetes Medicines
Bloomberg
Thursday, July 29, 2010 - 10:38am
tags:
earnings, Sanofi

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.